Assessment of histological features and outcome of interferon therapy in chronic hepatitis C
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in The Esophagus
- Vol. 31 (1) , 69-74
- https://doi.org/10.1007/bf01211189
Abstract
The correlation between the histological features of liver biopsy specimens before interferon (IFN) treatment and the clinical effect of IFN administration on chronic hepatitis C was investigated. A study of the relation between several histological features that were graded in 60 liver biopsy specimens from chronic hepatitis C patients before IFN treatment disclosed that the grade of portal fibrosis was positively correlated with the grade of other inflammatory features, including piecemeal necrosis and portal and lobular inflammation. The degree of portal fibrosis adversely affected the rate of normalization of ALT levels in chronic hepatitis C during and after IFN treatment. We reexamined 36 liver biopsy specimens that showed a moderate degree of portal fibrosis, and found that the degree of piecemeal necrosis was inversely correlated with the extent of lymphoid follicle formation in the portal tracts. During IFN therapy, the group of chronic hepatitis C patients who showed marked piecemeal necrosis and less lymphoid follicle formation in the liver specimens had a poor response to IFN treatment, whereas another group that showed marked lymphoid follicle formation and little piece-meal necrosis in the liver specimens had a good response to IFN. These relationships gradually disappeared after the completion of IFN treatment.Keywords
This publication has 24 references indexed in Scilit:
- Pathology of hepatitis CFEMS Microbiology Reviews, 1994
- Long–Term Follow–Up of Patients With Chronic Hepatitis C Treated With α–InterferonHepatology, 1992
- Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-αHepatology, 1992
- Successful treatment with interferon for a HCV-RNA positive patient with features of "autoimmune hepatitis".Kanzo, 1992
- Hepatitis C Virus Antibody in Patients With Chronic Autoimmune Hepatitis: Pitfalls in Diagnosis and Implications for TreatmentMayo Clinic Proceedings, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITISThe Lancet, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- The pathology of hepatitis A in manLiver International, 1982